Granisetron
1 NDC across 1 manufacturer|0 Generic,1 Brand
▸ More about this market▾ Less
The brand product was first FDA-approved on Sep 12, 2008. In 2024, Medicare Part D spent $7 million on Granisetron across 3,294 claims for 1,258 beneficiaries.
Granisetron is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $686.50 to $686.50 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$686.50 – $686.50
per EA
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing GRANISETRON
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
SANCUSO 3.1 MG/24 HR PATCH | $686.5040 per EA | — |
Frequently Asked Questions
How much does Medicare spend on Granisetron?
In 2024, Medicare Part D spent $7 million on Granisetron across 3,294 claims for 1,258 beneficiaries.
How many Granisetron products are on the market?
The Granisetron drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Granisetron?
NADAC reference prices for Granisetron range from $686.5040 to $686.5040 per EA.
Which manufacturers make Granisetron?
1 manufacturer lists Granisetron in NADAC. Ranked by number of NDCs, the largest are Cumberland Pharmaceuticals Inc. (1).